Dr (MD) Hannah Pressler

Dr Hannah Pressler is a postdoctoral researcher at the Department of Neurology with Experimental Neurology at Charité – Universitätsmedizin Berlin. Her research focuses on autoimmune-mediated neurological diseases. She also leads the IP/CIDP cohort (Immune-mediated polyneuropathy / chronic inflammatory demyelinating polyneuropathy (CIDP) – Diagnostic, prognostic, and therapy-response markers) at the NeuroCure Cluster of Excellence. Dr. Pressler is a member of the study team working on the IA-PACS-CFS trial, a randomised, controlled clinical trial investigating the efficacy of immunoadsorption in ME/CFS patients.